Atorvastatin Given prior to Electrical Cardioversion Does Not Affect the Recurrence of Atrial Fibrillation in Patients with Persistent Atrial Fibrillation Who Are on Antiarrhythmic Therapy

Publisher： Karger

E-ISSN： 1423-0151|20|5|464-469

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.20, Iss.5, 2011-07, pp. : 464-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Update on Electrical Cardioversion of Atrial Fibrillation

By Mittal S.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 3, 2003-09 ,pp. : 285-289

Springer Publishing Company

Access to resources Recommend Favorite

Electrophysiologic predictors of the recurrence of persistent atrial fibrillation within 30 days of cardioversion

By Raitt M.H.   Kusumoto W.   Giraud G.D.   McAnulty J.H.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

Persistent atrial fibrillation: a population based study of patients with their first cardioversion

By Lehto M.   Kala R.  

International Journal of Cardiology, Vol. 92, Iss. 2, 2003-12 ,pp. : 145-150

Elsevier

Access to resources Recommend Favorite

Facilitating Electrical Cardioversion of Persistant Atrial Fibrillation by Antiarrhythmic Drugs: Update on Clinical Trial Results

By Sung R.J.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 3, 2003-09 ,pp. : 300-303

Springer Publishing Company

Access to resources Recommend Favorite

Antiarrhythmic Therapy on Prevention of Postoperative Atrial Fibrillation in Patients After Heart Surgery

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 1, 2004-01 ,pp. : 29-34

Bentham Science Publishers

Access to resources Recommend Favorite